Exhaled 8-isoprostane as a possible prognostic marker in sarcoidosis

W. Piotrowski, Z. Kurmanowska, A. Antczak, J. Marczak, P. Górski (Lodz, Poland)

Source: Annual Congress 2009 - Sarcoidosis in review
Session: Sarcoidosis in review
Session type: Thematic Poster Session
Number: 703
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Piotrowski, Z. Kurmanowska, A. Antczak, J. Marczak, P. Górski (Lodz, Poland). Exhaled 8-isoprostane as a possible prognostic marker in sarcoidosis. Eur Respir J 2009; 34: Suppl. 53, 703

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD: Exhaled NO concentration and its prognostic value for smoking patient
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010


Exhaled 8-isoprostane as a marker of airway inflammation in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


Exhaled 8-isoprostane, a marker of oxidative stress, is increased in patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Sputum inflammatory biomarkers and exhaled nitric oxide (FENO) in varying severity asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Exhaled NO and other gases as biomarkers
Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Year: 2003

Exhaled nitric oxide is more a biomarker of atopy than asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways?
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006

Increased exhaled 8-isoprostane in childhood asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 141s
Year: 2002

Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010


Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Source: Eur Respir J 2006; 28: 1236-1244
Year: 2006



Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004

Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Exhaled nitric oxide as a biomarker in different COPD phenotypes
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Exhaled breath molecular profiling in measuring inflammatory status in COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008


Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation
Source: Eur Respir J 2003; 22: 392
Year: 2003